TY - JOUR T1 - Low-molecular-weight heparin offers no benefit to patients with unexplained recurrent miscarriage in future pregnancy JF - Evidence Based Medicine JO - Evid Based Med SP - 199 LP - 199 DO - 10.1136/ebmed-2015-110232 VL - 20 IS - 6 AU - Katie Field Y1 - 2015/12/01 UR - http://ebm.bmj.com/content/20/6/199.abstract N2 - Commentary on: Schleussner E, Kamin G, Seliger G, et al., ETHIG II group. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimislation randomisation scheme. Ann Intern Med 2015;162:601–9OpenUrlCrossRefPubMed.Recurrent miscarriage (RM) has been shown to affect between 1% and–3% of couples trying to conceive and up to 5% of those with two consecutive miscarriages are included. While there are many known risk factors for RM no underlying cause is found in nearly 50% of couples.1 The treatment of RM is usually aimed at the cause, which leaves us with very little to offer those with RM of unknown aetiology, and to date most of the treatment offered is … ER -